Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rakuto Bio-Technologies is an Israeli biotechnology company that specializes in the development, manufacturing, and distribution of enzyme-based products for industrial and life science applications. Established in 1990 and headquartered in Yokneam, the company provides specialized enzymatic solutions for the food and beverage, textile, detergent, and pulp and paper industries. In addition to its industrial focus, Rakuto Bio-Technologies serves the life science sector by offering reagents and enzymes for research and diagnostic purposes. The company was acquired by the global chemical distributor Brenntag in 2015, serving as a strategic hub for Brenntag's life science and food operations in the Mediterranean region. Today, it continues to operate as a subsidiary, leveraging its technical expertise to provide customized formulations and technical support to its clients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rakuto Bio Technologies.